A phosphoric ester (phosphate) that has an NR2 instead of an OH group.
ChEBI ID: 27577
Member | Definition | Role |
---|---|---|
fenamiphos | fenamiphos | |
gs-7340 | An L-alanine derivative that is isopropyl L-alaninate in which one of the amino hydrogens is replaced by an (S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl group. A prodrug for tenofovir, it is used (as the fumarate salt) in combination therapy for the treatment of HIV-1 infection. | tenofovir alafenamide |
propetamphos | propetamphos | |
s 8932 | A carboxylic ester resulting from the formal condensation of the carboxy group of N-[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-L-alanine with the hydroxy group of 2-ethylbutan-1-ol. A broad-spectrum antiviral prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus, MERS-CoV and SARS-CoV. It is currently in Phase III clinical trials for the treatment of Covid-19 in adults. | remdesivir |
sofosbuvir | A nucleotide conjugate that is used in combination with ledipasvir (under the trade name Harvoni) for the treatment of chronic hepatitis C genotype 1 infection. | sofosbuvir |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 15 (0.40) | 18.7374 |
1990's | 21 (0.56) | 18.2507 |
2000's | 40 (1.06) | 29.6817 |
2010's | 1,720 (45.61) | 24.3611 |
2020's | 1,975 (52.37) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 448 (11.37%) | 5.53% |
Reviews | 564 (14.31%) | 6.00% |
Case Studies | 381 (9.67%) | 4.05% |
Observational | 217 (5.51%) | 0.25% |
Other | 2,330 (59.14%) | 84.16% |